Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 2
2011 5
2012 3
2013 3
2014 1
2015 3
2016 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
SLC transporters as therapeutic targets: emerging opportunities.
Lin L, Yee SW, Kim RB, Giacomini KM. Lin L, et al. Nat Rev Drug Discov. 2015 Aug;14(8):543-60. doi: 10.1038/nrd4626. Epub 2015 Jun 26. Nat Rev Drug Discov. 2015. PMID: 26111766 Free PMC article. Review.
Trimethylamine-N-oxide: a link between the gut microbiome, bile acid metabolism, and atherosclerosis.
Wilson A, McLean C, Kim RB. Wilson A, et al. Curr Opin Lipidol. 2016 Apr;27(2):148-54. doi: 10.1097/MOL.0000000000000274. Curr Opin Lipidol. 2016. PMID: 26959704 Review.
The impact of obesity on the pharmacology of medications used for cardiovascular risk factor control.
Sankaralingam S, Kim RB, Padwal RS. Sankaralingam S, et al. Can J Cardiol. 2015 Feb;31(2):167-76. doi: 10.1016/j.cjca.2014.10.025. Epub 2014 Oct 28. Can J Cardiol. 2015. PMID: 25661551 Review.
Blood-brain barrier transporters and response to CNS-active drugs.
Urquhart BL, Kim RB. Urquhart BL, et al. Eur J Clin Pharmacol. 2009 Nov;65(11):1063-70. doi: 10.1007/s00228-009-0714-8. Eur J Clin Pharmacol. 2009. PMID: 19727692 Review.
Identification, expression, and functional characterization of full-length and splice variants of murine organic anion transporting polypeptide 1b2.
Meyer Zu Schwabedissen HE, Ware JA, Tirona RG, Kim RB. Meyer Zu Schwabedissen HE, et al. Mol Pharm. 2009 Nov-Dec;6(6):1790-7. doi: 10.1021/mp900030w. Mol Pharm. 2009. PMID: 19400585
Interaction of three regiospecific amino acid residues is required for OATP1B1 gain of OATP1B3 substrate specificity.
DeGorter MK, Ho RH, Leake BF, Tirona RG, Kim RB. DeGorter MK, et al. Mol Pharm. 2012 Apr 2;9(4):986-95. doi: 10.1021/mp200629s. Epub 2012 Mar 6. Mol Pharm. 2012. PMID: 22352740 Free PMC article.
Hepatic organic anion transporting polypeptide transporter and thyroid hormone receptor interplay determines cholesterol and glucose homeostasis.
Meyer zu Schwabedissen HE, Ware JA, Finkelstein D, Chaudhry AS, Mansell S, Leon-Ponte M, Strom SC, Zaher H, Schwarz UI, Freeman DJ, Schuetz EG, Tirona RG, Kim RB. Meyer zu Schwabedissen HE, et al. Hepatology. 2011 Aug;54(2):644-54. doi: 10.1002/hep.24391. Epub 2011 Jun 26. Hepatology. 2011. PMID: 21538436 Free PMC article.
Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms.
Meyer zu Schwabedissen HE, Verstuyft C, Kroemer HK, Becquemont L, Kim RB. Meyer zu Schwabedissen HE, et al. Am J Physiol Renal Physiol. 2010 Apr;298(4):F997-F1005. doi: 10.1152/ajprenal.00431.2009. Epub 2010 Jan 6. Am J Physiol Renal Physiol. 2010. PMID: 20053795 Free article.
Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
Kim RB, Morse BL, Djurdjev O, Tang M, Muirhead N, Barrett B, Holmes DT, Madore F, Clase CM, Rigatto C, Levin A; CanPREDDICT Investigators. Kim RB, et al. Kidney Int. 2016 May;89(5):1144-1152. doi: 10.1016/j.kint.2016.01.014. Epub 2016 Mar 19. Kidney Int. 2016. PMID: 27083288
Drug transporters in drug efficacy and toxicity.
DeGorter MK, Xia CQ, Yang JJ, Kim RB. DeGorter MK, et al. Annu Rev Pharmacol Toxicol. 2012;52:249-73. doi: 10.1146/annurev-pharmtox-010611-134529. Epub 2011 Sep 19. Annu Rev Pharmacol Toxicol. 2012. PMID: 21942630 Review.
18 results
Jump to page